{"id":"W3029883096","doi":"10.1200/jco.2020.38.15_suppl.tps6104","title":"DUETTE: A randomized phase II study to assess a second maintenance treatment with olaparib (ola) or ola+ceralasertib (cer), in patients (pts) with platinum-sensitive relapsed (PSR) epithelial ovarian cancer who have previously received PARP inhibitor maintenance treatment (NCT04239014).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Olaparib; Ovarian cancer; Oncology; BRCA mutation; Population; Internal medicine; Cancer; Clinical trial; Maintenance therapy; Chemotherapy; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001531918,0.001476125,0.001984817,0.0003578688,0.0003997592,0.001378242,0.001085078,0.001977367,0.01186256],"category_scores_gemma":[0.001344636,0.000554189,0.00172668,0.0003027361,0.0008646605,0.001648857,0.0005544963,0.003157124,0.001597452],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008996482,"about_ca_system_score_gemma":0.001334576,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006469052,"about_ca_topic_score_gemma":0.002192792,"domain_scores_codex":[0.9996793,0.0001451768,0.00001459933,0.00006893146,0.00002988613,0.00006200942],"domain_scores_gemma":[0.9992658,0.0001282412,0.000164085,0.00006620975,0.00003659858,0.0003390714],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9255179,0.01971461,0.001380872,0.0009804948,0.0009211145,0.00009762223,0.00008034537,0.000704183,0.008388167,0.000405546,0.00423699,0.03757212],"study_design_scores_gemma":[0.8666227,0.1268955,0.002186517,0.00004792448,0.0002508902,0.00008985918,0.00002428393,0.0005794117,0.0004203407,0.000314027,0.002550601,0.00001781173],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9603931,0.007446058,0.002215448,0.002339599,0.001692513,0.01314218,0.005104358,0.0003978431,0.007268938],"genre_scores_gemma":[0.9461177,0.004234808,0.004123374,0.004647209,0.0008792534,0.01900663,0.006464088,0.0000903105,0.01443658],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01186256,"threshold_uncertainty_score":0.03968418,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09539568677493485,"score_gpt":0.4226898474471354,"score_spread":0.3272941606722005,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}